|
Fusion gene ID: 24570 |
FusionGeneSummary for NOLC1_HTR7 |
Fusion gene summary |
Fusion gene information | Fusion gene name: NOLC1_HTR7 | Fusion gene ID: 24570 | Hgene | Tgene | Gene symbol | NOLC1 | HTR7 | Gene ID | 9221 | 3363 |
Gene name | nucleolar and coiled-body phosphoprotein 1 | 5-hydroxytryptamine receptor 7 | |
Synonyms | NOPP130|NOPP140|NS5ATP13|P130 | 5-HT7 | |
Cytomap | 10q24.32 | 10q23.31 | |
Type of gene | protein-coding | protein-coding | |
Description | nucleolar and coiled-body phosphoprotein 1140 kDa nucleolar phosphoproteinHCV NS5A trans-regulated protein 13HCV NS5A-transactivated protein 13hepatitis C virus NS5A-transactivated protein 13nucleolar 130 kDa proteinnucleolar and coiled-body phosphp | 5-hydroxytryptamine receptor 75-HT-75-HT-X5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q14978 | P34969 | |
Ensembl transtripts involved in fusion gene | ENST00000605788, ENST00000405356, ENST00000603742, ENST00000488254, ENST00000477977, | ENST00000371721, ENST00000277874, ENST00000336152, ENST00000371719, | |
Fusion gene scores | * DoF score | 7 X 7 X 2=98 | 1 X 1 X 1=1 |
# samples | 8 | 1 | |
** MAII score | log2(8/98*10)=-0.292781749227846 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
Context | PubMed: NOLC1 [Title/Abstract] AND HTR7 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | UCS | TCGA-NG-A4VU-01A | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000605788 | ENST00000371721 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000605788 | ENST00000277874 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000605788 | ENST00000336152 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000605788 | ENST00000371719 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000405356 | ENST00000371721 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000405356 | ENST00000277874 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000405356 | ENST00000336152 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000405356 | ENST00000371719 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
5UTR-3CDS | ENST00000603742 | ENST00000371721 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
5UTR-3CDS | ENST00000603742 | ENST00000277874 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
5UTR-3CDS | ENST00000603742 | ENST00000336152 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
5UTR-3CDS | ENST00000603742 | ENST00000371719 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000488254 | ENST00000371721 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000488254 | ENST00000277874 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000488254 | ENST00000336152 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Frame-shift | ENST00000488254 | ENST00000371719 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
intron-3CDS | ENST00000477977 | ENST00000371721 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
intron-3CDS | ENST00000477977 | ENST00000277874 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
intron-3CDS | ENST00000477977 | ENST00000336152 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
intron-3CDS | ENST00000477977 | ENST00000371719 | NOLC1 | chr10 | 103912287 | + | HTR7 | chr10 | 92509351 | - |
Top |
FusionProtFeatures for NOLC1_HTR7 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
NOLC1 | HTR7 |
Nucleolar protein that acts as a regulator of RNApolymerase I by connecting RNA polymerase I with enzymesresponsible for ribosomal processing and modification(PubMed:10567578, PubMed:26399832). Required for neural crestspecification: following monoubiquitination by the BCR(KBTBD8)complex, associates with TCOF1 and acts as a platform to connectRNA polymerase I with enzymes responsible for ribosomal processingand modification, leading to remodel the translational program ofdifferentiating cells in favor of neural crest specification(PubMed:26399832). Involved in nucleologenesis, possibly byplaying a role in the maintenance of the fundamental structure ofthe fibrillar center and dense fibrillar component in thenucleolus (PubMed:9016786). It has intrinsic GTPase and ATPaseactivities (PubMed:9016786). {ECO:0000269|PubMed:10567578,ECO:0000269|PubMed:26399832, ECO:0000269|PubMed:9016786}. | This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functionsas a neurotransmitter, a hormone, and a mitogen. The activity ofthis receptor is mediated by G proteins that stimulate adenylatecyclase. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NOLC1_HTR7 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NOLC1_HTR7 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
NOLC1 | ARRB2, ARRB1, YWHAZ, COIL, POLR1A, CEBPB, CSNK2B, MME, NOP56, YWHAG, CHD4, SIRT7, CHMP4B, GRK5, APP, FBL, RPS14, RSL1D1, NHP2L1, RPL15, RPL23A, RPL18A, RPL19, RPL6, RPL11, NOP58, RPS6, RPS23, RPL5, RPL4, RPS4X, RRP7A, UTP14A, PTRF, IK, NOP16, GPRC5A, RRS1, G3BP1, SAP18, GTF3C1, PNKP, PAN2, YWHAE, YWHAQ, CD2AP, SPAG9, RABEP2, WWOX, ERG, CSNK2A2, MOV10, NXF1, CUL7, OBSL1, SUZ12, EED, RNF2, CSNK2A1, FAM9A, DENND2D, BRIX1, CDK11A, CEBPZ, DDX56, DHX15, NOP2, PELP1, SRP14, SRRM1, SUB1, SSRP1, WDR36, SCARNA22, SRPK2, CC2D2A, XPO1, ATM, MKNK2, HDAC1, KLC1, KIF11, LLGL2, SUPT5H, TMPO, EZR, MYH13, VPS26A, ING4, POLK, KIF21A, KLC3, CEP170P1, MCM2, CDC5L, OTUB1, DAXX, KBTBD8, TCOF1, POLR1B, DKC1, NHP2, MDM2, CAMKV, PIP4K2A, GRK6, GTF2IRD1, RAB11FIP1, TWISTNB, HOXB9, AP3B1, EAF1, POLD1, CCDC154, MFAP1, COX15, DLD, HEY1, BRCA1, TES | HTR7 | RHOBTB3, CUL3, GPRASP1, GPRASP2 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NOLC1_HTR7 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | NOLC1 | Q14978 | DB00997 | Doxorubicin | Nucleolar and coiled-body phosphoprotein 1 {ECO:0000305} | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB00246 | Ziprasidone | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00247 | Methysergide | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00248 | Cabergoline | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00321 | Amitriptyline | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00363 | Clozapine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00370 | Mirtazapine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00408 | Loxapine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00434 | Cyproheptadine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00458 | Imipramine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00543 | Amoxapine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00988 | Dopamine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB01224 | Quetiapine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB01267 | Paliperidone | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB04946 | Iloperidone | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB06216 | Asenapine | 5-hydroxytryptamine receptor 7 | small molecule | approved |
Tgene | HTR7 | P34969 | DB00216 | Eletriptan | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB00334 | Olanzapine | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB00589 | Lisuride | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB00734 | Risperidone | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB00751 | Epinastine | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB00934 | Maprotiline | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB01200 | Bromocriptine | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB01238 | Aripiprazole | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB06148 | Mianserin | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB06288 | Amisulpride | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB08815 | Lurasidone | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB09068 | Vortioxetine | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational |
Tgene | HTR7 | P34969 | DB00477 | Chlorpromazine | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational|vet_approved |
Tgene | HTR7 | P34969 | DB09225 | Zotepine | 5-hydroxytryptamine receptor 7 | small molecule | approved|investigational|withdrawn |
Top |
RelatedDiseases for NOLC1_HTR7 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | HTR7 | C0011581 | Depressive disorder | 6 | CTD_human;PSYGENET |
Tgene | HTR7 | C0011570 | Mental Depression | 5 | PSYGENET |
Tgene | HTR7 | C0001973 | Alcoholic Intoxication, Chronic | 2 | PSYGENET |
Tgene | HTR7 | C0003469 | Anxiety Disorders | 1 | CTD_human |
Tgene | HTR7 | C0023186 | Learning Disorders | 1 | CTD_human |
Tgene | HTR7 | C0025261 | Memory Disorders | 1 | CTD_human |
Tgene | HTR7 | C0026848 | Myopathy | 1 | CTD_human |
Tgene | HTR7 | C0030193 | Pain | 1 | CTD_human |
Tgene | HTR7 | C0036341 | Schizophrenia | 1 | CTD_human |
Tgene | HTR7 | C0525045 | Mood Disorders | 1 | PSYGENET |
Tgene | HTR7 | C4042891 | Sleep Wake Disorders | 1 | CTD_human |